Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity

Xenotransplantation

Volumn 14, Issue 2, 2007, Pages 126-134

  Lilienfeld, Benjamin G ^a   Crew, Mark D ^b   Forte, Pietro ^a   Baumann, Bettina C ^a   Seebach, Jörg D ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

CD94 NKG2A; Cytotoxicity; HLA E; Natural killer cells

Indexed keywords

BETA 2 MICROGLOBULIN; CALCIUM PHOSPHATE; CD94 ANTIGEN; CHROMIUM 51; HLA E ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2A; PEPTIDE; UNCLASSIFIED DRUG; VALYLMETHIONYLALANYLPROLYLARGINYLTHREONYLLEUCYLISOLEUCYLLEUCINE;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL INTERACTION; CONJUGATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; HEAVY CHAIN; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MOLECULAR CLONING; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, HETEROPHILE; ANTIGENS, CD94; CELL ADHESION; CELL COMMUNICATION; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; SWINE; TRANSFECTION; TRANSGENES; TRANSPLANTATION, HETEROLOGOUS;

EID: 33947394796     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2007.00378.x     Document Type: Article

References (39)

1. CASCALHO M, PLATT JL. The immunological barrier to xenotransplantation. Immunity 2001; 14: 437.
2. SEEBACH JD, WANECK GL. Natural killer cells in xeno-transplantation. Xenotransplantation 1997; 4: 201.
3. KITCHENS WH, UEHARA S, CHASE CM et al. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 2006; 81: 811.
4. GOODMAN DJ, VON ALBERTINI M, WILLSON A, MILLAN MT, BACH FH. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation 1996; 61: 763.
5. RIEBEN R, SEEBACH JD. Xenograft rejection: IgG(1), complement and NK cells team up to activate and destroy the endothelium. Trends Immunol 2005; 26: 2.
6. KHALFOUN B, BARRAT D, WATIER H et al. Development of an ex vivo model of pig kidney perfused with human lymphocytes. Analysis of xenogeneic cellular reactions. Surgery 2000; 128: 447.
7. INVERARDI L, PARDI R. Early events in cell-mediated recognition of vascularized xenografts: cooperative interactions between selected lymphocyte subsets and natural antibodies. Immunol Rev 1994; 141: 71.
8. ITESCU S, KWIATKOWSKI P, ARTRIP JH et al. Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period. Hum Immunol 1998; 59: 275.
9. LIN Y, VANDEPUTTE M, WAER M. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol 1997; 158: 5658.
10. XIA G, JI P, RUTGEERTS O, WAER M. Natural killer cell-and macrophage mediated discordant guinea pig->rat xenograft rejection in the absence of complement, xeno-antibody and T cell immunity. Transplantation 2000; 70: 86.
11. YI S, FENG X, HAWTHORNE WJ et al. CD4+ T cells initiate pancreatic islet xenograft rejection via an interferon-gamma-dependent recruitment of macrophages and natural killer cells. Transplantation 2002; 73: 437.
12. MORETTA L, MORETTA A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 2004; 23: 255.
13. MORETTA A, BOTTINO C, VITALE M et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19: 197-223.
14. RAULET DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003; 3: 781.
15. FORTE P, LILIENFELD BG, BAUMANN BC, SEEBACH JD. Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D. J Immunol 2005; 175: 5463.
16. LILIENFELD BG, GARCIA-BORGES C, CREW MD, SEEBACH JD. Porcine UL16-binding protein 1 expressed on the surface of endothelial cells triggers human NK cytotoxicity through NKG2D. J Immunol 2006; 177: 2146.
17. ANDRE P, BIASSONI R, COLONNA M et al. New nomenclature for MHC receptors. Nat Immunol 2001; 2: 661.
18. SULLIVAN JA, OETTINGER HF, SACHS DH, EDGE AS. Analysis of polymorphism in porcine MHC class I genes: alterations in signals recognized by human cytotoxic lymphocytes. J Immunol 1997; 159: 2318.
19. BORREGO F, ULBRECHT M, WEISS EH, COLIGAN JE, BROOKS AG. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 1998; 187: 813.
20. LEE N, LLANO M, CARRETERO M et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A 1998; 95: 5199.
21. WEI XH, ORR HT. Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue. Hum Immunol 1990; 29: 131.
22. SEEBACH JD, COMRACK C, GERMANA S et al. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. J Immunol 1997; 159: 3655.
23. FORTE P, PAZMANY L, MATTER-REISSMANN UB et al. HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells. J Immunol 2001; 167: 6002.
24. SHARLAND A, LEE JH, SAIDMAN S, WANECK GL. CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes. Transplantation 2003; 76: 1615.
25. SASAKI H, XU XC, MOHANAKUMAR T. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways. J Immunol 1999; 163: 6301.
26. MATSUNAMI K, MIYAGAWA S, NAKAI R, YAMADA M, SHIRAKURA R. Modulation of the leader peptide sequence of the HLA-E gene up-regulates its expression and downregulates natural killer cell-mediated swine endothelial cell lysis. Transplantation 2002; 73: 1582.
27. SHARLAND A, PATEL A, LEE JH et al. Genetically modified HLA class I molecules able to inhibit human NK cells without provoking alloreactive CD8+ CTLs. J Immunol 2002; 168: 3266.
28. FORTE P, BAUMANN BC, WEISS EH, SEEBACH JD. HLA-E expression on porcine cells: protection from human NK cytotoxicity depends on peptide loading. Am J Transplant 2005; 5: 2085.
29. CREW MD, CANNON MJ, PHANAVANH B, GARCIA-BORGES CN. An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells. Mol Immunol 2005; 42: 1205.
30. BURSHTYN DN, SHIN J, STEBBINS C, LONG EO. Adhesion to target cells is disrupted by the killer cell inhibitory receptor. Curr Biol 2000; 10: 777.
31. SEEBACH JD, SCHNEIDER MK, COMRACK CA et al. Immortalized bone-marrow derived pig endothelial cells. Xenotransplantation 2001; 8: 48.
32. CARRILLO A, CHAMORRO S, RODRIGUEZ-G AGO M et al. Isolation and characterization of immortalized porcine aortic endothelial cell lines. Vet Immunol Immunopathol 2002; 89: 91.
33. HUANG CA, FUCHIMOTO Y, GLEIT ZL et al. Posttransplantation lymphoproliferative disease in miniature swine after allogeneic hematopoietic cell transplantation: similarity to human PTLD and association with a porcine gammaherpesvirus. Blood 2001; 97: 1467.
34. LEE N, GOODLETT DR, ISHITANI A, MARQUARDT H, GERAGHTY DE. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 1998; 160: 4951.
35. SEEBACH JD, YAMADA K, MCMORROW I, SACHS DH, DERSIMONIAN H. Xenogeneic human anti-pig cytotoxicity mediated by activated natural killer cells. Xenotransplantation 1996; 3: 188.
36. SCHNEIDER MK, FORTE P, SEEBACH JD. Adhesive interactions between human NK cells and porcine endothelial cells. Scand J Immunol 2001; 54: 70.
37. TROWSDALE J. HLA genomics in the third millennium. Curr Opin Immunol 2005; 17: 498.
38. VALES-GOMEZ M, REYBURN HT, ERSKINE RA, LOPEZ-BOTET M, STROMINGER JL. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J 1999; 18: 4250.
39. SUTHERLAND CL, CHALUPNY NJ, COSMAN D. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunol Rev 2001; 181: 185.